Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17 is a recently described cytokine involved in the amplification of inflammatory responses and pathologies. A hallmark feature of IL-17 is its ability to induce expression of other cytokines and chemokines. In addition, IL-17 potently synergizes with tumor necrosis factor-alpha (TNFalpha) to up-regulate expression of many target genes, particularly IL-6. Despite the many observations of IL-17 signaling synergy observed to date, little is known about the molecular mechanisms that underlie this phenomenon. In the osteoblastic cell line MC-3T3, we have found that IL-17 and TNFalpha exhibit potent synergy in mediating IL-6 secretion. Here, we show that at least part of the functional cooperation between IL-17 and TNFalpha occurs at the level of IL-6 gene transcription. Both the NF-kappaB and CCAAT/enhancer-binding protein (C/EBP; NF-IL6) sites in the IL-6 promoter are important for cooperative gene expression, but NF-kappaB does not appear to be the direct target of the combined signal. Microarray analysis using the Affymetrix mouse MG-U74v2 chip identified C/EBPdelta as another gene target of combined IL-17- and TNFalpha-induced signaling. Because C/EBP family members are known to control IL-6, we examined whether enhanced C/EBPdelta expression is involved in the cooperative up-regulation of IL-6 by IL-17 and TNFalpha. Accordingly, we show that C/EBPdelta (or the related transcription factor C/EBPbeta) is essential for expression of IL-6. Moreover, overexpression of C/EBPdelta (and, to a lesser extent, C/EBPbeta) could substitute for the IL-17 signal at the level of IL-6 transcription. Thus, C/EBP family members, particularly C/EBPdelta, appear to be important for the functional cooperation between IL-17 and TNFalpha.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NF-κB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“In addition to synergizing with strong NF-κB activators such as TNFα, lipopolysaccharide (LPS), IL-1β and lymphotoxin, IL-17 cooperates with IFNγ (activator of STAT1), IL-13 (STAT6), TGFβ (SMADs), fibroblast growth factor (FGF)2 (Ras:Raf) and a Candida albicans-derived pore-forming toxin from Candida albicans (c-Fos)”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One of the best-studied examples of synergy is with TNFα”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One curious aspect of IL-17 biology is that this cytokine is consistently a modest activator of signaling in vitro, regardless of the cell system analyzed”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
Citations
Cites
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Neutrophil Recruitment by Human IL-17 Via C-X-C Chemokine Release in the Airways
Laan, M., Cui, Z.-H., Hoshino, H., Lötvall, J., Sjöstrand, M., Gruenert, D. C., Skoogh, B.-E., & Lindén, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2347 · Cited by 880
Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G., & Thompson, C. B. (1989) · Science · doi:10.1126/science.2540528 · Cited by 878
Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Pelletier, J.-P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3513 · Cited by 867
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
IL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Bellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 430
Activation of Interleukin-6 Gene Expression through the NF-κB Transcription Factor
Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327-2334.1990 · Cited by 403
Shalom-Barak, T., Quach, J., & Lotz, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27467 · Cited by 388
Albanesi, C., Cavani, A., & Girolomoni, G. (1999) · PubMed · Cited by 355
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Lubberts, E., van den Bersselaar, L., Oppers-Walgreen, B., Schwarzenberger, P., Coenen-de Roo, C. J. J., Kolls, J. K., Joosten, L. A. B., & van den Berg, W. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2655 · Cited by 348
Albanesi, C., Cavani, A., & Girolomoni, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.494 · Cited by 307
Witowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A., Friess, H., Gahl, G. M., Frei, U., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5814 · Cited by 305
Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 303
Offenbaecher, M., Bondy, B., Jonge, S. D., Glatzeder, K., Kr�ger, M., Schoeps, P., & Ackenheil, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2482::aid-anr27>3.0.co;2-b · Cited by 298
Miossec, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10816 · Cited by 264
Ray, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256
Chabaud, M., & Miossec, P. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1293::aid-art221>3.0.co;2-t · Cited by 197
Eickelberg, O., Pansky, A., Mussmann, R., Bihl, M., Tamm, M., Hildebrand, P., Perruchoud, A. P., & Roth, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12933 · Cited by 185
Interleukin-17: A New Bone Acting Cytokine In Vitro
Van Bezooijen, R. L., Farih-Sips, H. C. M., Papapoulos, S. E., & Löwik, C. W. G. M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1513 · Cited by 168
Martel-Pelletier, J., Mineau, F., Jovanovic, D., Di Battista, J. A., & Pelletier, J.-P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2399::aid-anr19>3.0.co;2-y · Cited by 165
Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1
Cantwell, C. A., Sterneck, E., & Johnson, P. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2108 · Cited by 162
IL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory Mediators
Shimada, M., Andoh, A., Hata, K., Tasaki, K., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.861 · Cited by 142
Maertzdorf, J., Osterhaus, A. D. M. E., & Verjans, G. M. G. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5897 · Cited by 138
WOLTMAN, A. M., DE HAIJ, S., BOONSTRA, J. G., GOBIN, S. J. P., DAHA, M. R., & KOOTEN, C. V. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11112044 · Cited by 130
Transcription factors: A practical approach
Little, M. H. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90145-8 · Cited by 108
Anticytokine Therapy — A New Era in the Treatment of Rheumatoid Arthritis?
O'Dell, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400411 · Cited by 104
Gaffen, S. L., Lai, S. Y., Xu, W., Gouilleux, F., Groner, B., Goldsmith, M. A., & Greene, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7192 · Cited by 93
Self-citationThe Mammalian Transcriptional Repressor RBP (CBF1) Regulates Interleukin-6 Gene Expression
Kannabiran, C., Zeng, X., & Vales, L. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.1 · Cited by 91
CD40 Induces Interleukin-6 Gene Transcription in Dendritic Cells
Mann, J., Oakley, F., Johnson, P. W. M., & Mann, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109250200 · Cited by 90
TNFα Is an Effective Therapeutic Target for Rheumatoid Arthritisa
FELDMANN, M., BRENNAN, F. M., ELLIOTT, M. J., WILLIAMS, R. O., & MAINI, R. N. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26675.x · Cited by 80
van Bezooijen, R. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Bone · doi:10.1016/s8756-3282(00)00457-9 · Cited by 72
Andoh, A., Fujino, S., Bamba, S., Araki, Y., Okuno, T., Bamba, T., & Fujiyama, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1683 · Cited by 64
Umayahara, Y., Billiard, J., Ji, C., McCarthy, T. L., & Rotwein, P. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10609 · Cited by 57
Katz, Y., Nadiv, O., Rapoport, M. J., & Loos, M. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01199.x · Cited by 53
Andoh, A., Shimada, M., Bamba, S., Okuno, T., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00250-1 · Cited by 41
Yamada, T., Tsuchiya, T., Osada, S., Nishihara, T., & Imagawa, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7915 · Cited by 40
Binding of C/EBP and RBP (CBF1) to Overlapping Sites Regulates Interleukin-6 Gene Expression
Vales, L. D., & Friedl, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207363200 · Cited by 35
Yamamoto, H., Kurebayashi, S., Hirose, T., Kouhara, H., & Kasayama, S. (2002) · Journal of Cell Science · doi:10.1242/jcs.00044 · Cited by 34
Self-citationMiguel, F. D., Martínez-Fernández, P., Guillén, C., Valín, Á., RODRIGO, A., MARTINEZ, M. E., & Esbrit, P. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104796 · Cited by 33
Takaya, H., Andoh, A., Makino, J., Shimada, M., Tasaki, K., Araki, Y., Bamba, S., Hata, K., Fujiyama, Y., & Bamba, T. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202753416948 · Cited by 31
Andoh, A., Hata, K., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.10.5.631 · Cited by 30
Research works printed but not linked: 2
- Libermann, 1990, Mol. Cell. Biol., 10, 2327
- Andoh, 2002, Int. J. Mol. Med., 10, 631
Cited by
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
“Furthermore, TNF-α and IL-6, which are both produced by Th17 cells, not only support Th17 cell development but also synergize with IL-17 to enhance the production of proinflammatory mediators (76).”
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationStructure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
“Gel shift studies indicated that IL-17A activates p50 and p65 , which are components of the canonical NF-κB pathway”
Self-citation
Metadata
- Authors
- Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L.
- Affiliations
- University at Buffalo, State University of New York (US)
- The University of Osaka (JP)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 4
- Pages
- 2559-2567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087851913
- Cited by
- 364
- References
- 54
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 20 · 2021: 24 · 2020: 14 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 14 · 2015: 20 · 2014: 22 · 2013: 13 · 2012: 18
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6134 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI49329, AI 07614, T32AI007614)
- National Institute of Dental and Craniofacial Research (DE14460, R03DE014460)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- IL-17, TNF-α, C/EBP family, C/EBPδ, C/EBPβ, cytokine synergy, NF-κB, IL-6 promoter, transcriptional regulation
- MeSH terms
- Animals, Cell Line, Drug Synergism, Osteoblasts, Tumor Necrosis Factor-alpha, Signal Transduction, Transcriptional Activation, Interleukin-6, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.